300401.SZ
Zhejiang Garden Biopharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 14.14
−8.42%Year over year
Reported trailing growth
- Revenue
- -4.2%
- EBITDA
- —
- EBIT
- -16.0%
- EPS
- -18.6%
- Free cash flow
- +1696.2%
- Operating cash flow
- +6.2%
Forward estimates
Based on analyst estimates
- Revenue
- -64.7%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -4.4%
- EBITDA
- +2.1%
- EBIT
- -7.1%
- Net income
- -7.4%
- EPS
- -7.2%
- Free cash flow
- +907.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026